Alpha Tau Medical News - DRTS

Company Name	Stock Ticker Symbol	Market	Type
Alpha Tau Medical Ltd	DRTS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	2.44	04:29:36

Open Price	Low Price	High Price	Close Price	Prev Close
				2.44

more quote information »

Recent News

Date	Time	Source	Heading
4/22/2024	8:49	IHNW	FeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
3/25/2024	08:50	GLOBE	Alpha Tau to Present at the Jefferies Radiopharma Innovation..
3/07/2024	16:13	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
3/07/2024	16:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/07/2024	16:01	GLOBE	Alpha Tau Medical Announces Full Year 2023 Financial Results..
2/26/2024	08:32	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/26/2024	08:30	GLOBE	Alpha Tau to Participate in Barclays 26th Annual Global..
12/20/2023	09:16	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/2023	09:15	GLOBE	Alpha Tau to Present at the 42nd Annual J.P. Morgan..
12/18/2023	11:09	EDGAR2	Form 144 - Report of proposed sale of securities
11/29/2023	08:35	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/29/2023	08:30	GLOBE	Alpha Tau to Participate in Sidoti Small-Cap Conference
11/28/2023	08:35	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/28/2023	08:30	GLOBE	Alpha Tau Announces Highly Promising Interim Results from..
11/21/2023	06:18	EDGAR2	Form 144 - Report of proposed sale of securities
11/20/2023	08:35	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/20/2023	08:30	GLOBE	Alpha Tau Submits to Japanese PMDA for Pre-Market Approval..
11/16/2023	16:32	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/16/2023	16:30	GLOBE	Alpha Tau Medical Announces Third Quarter 2023 Financial..
11/01/2023	17:18	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/01/2023	08:32	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/30/2023	08:31	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/30/2023	08:30	GLOBE	Alpha Tau Enters Into Long-Term Lease of Site in New..
10/24/2023	09:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/24/2023	09:00	GLOBE	Former U.S. Commissioner of Food and Drug Administration..
9/27/2023	07:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/25/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
9/14/2023	08:32	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/14/2023	08:30	GLOBE	Alpha Tau Treats First Patient with Advanced Inoperable..
9/11/2023	16:16	EDGAR2	Form F-3 - Registration statement by foreign private issuers
8/28/2023	16:15	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/28/2023	16:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/28/2023	16:02	GLOBE	Alpha Tau Medical Announces Second Quarter 2023 Financial..
8/24/2023	08:02	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/17/2023	17:02	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/17/2023	17:00	GLOBE	Alpha Tau Announces Robust Long-Term Safety and Efficacy..
8/02/2023	09:02	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/24/2023	16:01	GLOBE	Alpha Tau Medical to Participate in June Investor..
5/23/2023	16:01	GLOBE	Alpha Tau Medical Announces First Quarter 2023 Financial..
5/17/2023	16:30	GLOBE	Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer..
5/11/2023	16:00	GLOBE	Alpha Tau Announces the Publication of its US Multicenter..
5/03/2023	16:00	GLOBE	Alpha Tau Medical to Present at Guggenheim..